Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6540-6548

  Frasch, S Courtney ^a   Zemski Berry, Karin ^b   Murphy, Robert C ^b   Borregaard, Niels ^c   Henson, Peter M ^a,b   Bratton, Donna L ^a,d  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Rigshospitalet   (Denmark)

^d Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ALBUMIN; CALCIUM; CD45 ANTIGEN; CHOLINE DERIVATIVE; G PROTEIN COUPLED RECEPTOR; G2A PROTEIN; LYSOPHOSPHOLIPID; PERTUSSIS TOXIN; PHOSPHOETHANOLAMINE; PHOSPHOLIPASE C; PHOSPHOSERINE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MOTILITY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SECRETORY VESICLE; STIMULATION; WESTERN BLOTTING;

EID: 34248182983     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6540     Document Type: Article

References (68)

1. Muller, J., M. Petkovic, J. Schiller, K. Arnold, S. Reichl, and J. Arnhold. 2002. Effects of lysophospholipids on the generation of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils. Luminescence 17: 141-149.
2. Lin, P., E. J. Welch, X. P. Gao, A. B. Malik, and R. D. Ye. 2005. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J. Immunol. 174: 2981-2989.
3. Jing, Q., S. M. Xin, W. B. Zhang, P. Wang, Y. W. Qin, and G. Pei. 2000. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ. Res. 87: 52-59.
4. 2+ level in Jurkat T cell line. Immunol. Lett. 91: 17-21.
5. Silliman, C. C., D. J. Elzi, D. R. Ambruso, R. J. Musters, C. Hamiel, R. J. Harbeck, A. J. Paterson, A. J. Bjomsen, T. H. Wyman, M. Kelher, et al. 2003. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukocyte Biol. 73: 511-524.
6. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
7. Yan, J. J., J. S. Jung, J. E. Lee, J. Lee, S. O. Huh, H. S. Kim, K. C. Jung, J. Y. Cho, J. S. Nam, H. W. Suh, et al. 2004. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10: 161-167.
8. Ginsburg, I., P. A. Ward, and J. Varani. 1989. Lysophosphatides enhance superoxide responses of stimulated human neutrophils. Inflammation 13: 163-174.
9. Tomura, H., C. Mogi, K. Sato, and F. Okajima. 2005. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors. Cell. Signal. 17: 1466-1476.
10. Kabarowski, J. H., K. Zhu, L. Q. Le, O. N. Witte, and Y. Xu. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293: 702-705.
11. Wang, L., C. G. Radu, L. V. Yang, L. A. Bentolila, M. Riedinger, and O. N. Witte. 2005. Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. Mol. Biol. Cell 16: 2234-2247.
12. Witte, O. N., J. H. Kabarowski, Y. Xu, L. Q. Le, and K. Zhu. 2005. Retraction. Science 307: 206.
13. Obinata, H., T. Hattori, S. Nakane, K. Tatei, and T. Izumi. 2005. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J. Biol. Chem. 280: 40676-40683.
14. Itagaki, K., and C. J. Hauser. 2003. Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. J. Biol. Chem. 278: 27540-27547.
15. Llanos, M. N., P. Morales, and M. S. Riffo. 1993. Studies of lysophospholipids related to the hamster sperm acrosome reaction in vitro. J. Exp. Zool. 267: 209-216.
16. Gay, I., Z. Schwartz, V. L. Sylvia, and B. D. Boyan. 2004. Lysophospholipid regulates release and activation of latent TGF-β1 from chondrocyte extracellular matrix. Biochim. Biophys. Acta 1684: 18-28.
17. Wilson-Ashworfh, H. A., A. M. Judd, R. M. Law, B. D. Freestone, S. Taylor, M. K. Mizukawa, K. R. Cromar, S. Sudweeks, and J. D. Bell. 2004. Formation of transient non-protein calcium pores by lysophospholipids in S49 lymphoma cells. J. Membr. Biol. 200: 25-33.
18. 2. J. Biol. Chem. 274: 11494-11504.
19. Haslett, C., L. A. Guthrie, M. M. Kopaniak, R. B. Johnston, Jr., and P. M. Henson. 1985. Modulation of multiple neutrophil functions by preparative methods and trace amounts of bacterial lipopolysaccharide. Am. J. Pathol. 119: 101-110.
20. Parks, B. W., G. P. Gambill, A. J. Lusis, and J. H. Kabarowski. 2005. Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J. Lipid Res. 46: 1405-1415.
21. Kjeldsen, L., H. Sengelov, and N. Borregaard. 1999. Subcellular fractionation of human neutrophils on Percoll density gradients. J. Immunol. Methods 232: 131-143.
22. Itagaki, K., K. B. Kannan, and C. J. Hauser. 2005. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. J. Leukocyte Biol. 77: 181-189.
23. Xu, Y., Y. J. Xiao, K. Zhu, L. M. Baudhuin, J. Lu, G. Hong, K. S. Kim, K. L. Cristina, L. Song, S. F. Williams, et al. 2003. Unfolding the pathophysiological role of bioactive lysophospholipids. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3: 23-32.
24. Xu, Y. 2002. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled, receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 1582: 81-88.
25. Zhu, K., L. M. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. Kabarowski, O. N. Witte, and Y. Xu. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276: 41325-41335.
26. Bratton, D. L., J. M. Kailey, K. L. Clay, and P. M. Henson. 1991. A model for the extracellular release of PAF: the influence of plasma membrane phospholipid asymmetry. Biochim. Biophys. Acta 1062: 24-34.
27. Bratton, D. L. 1993. Release of platelet activating factor from activated neutrophils: transglutaminase-dependent enhancement of transbilayer movement across the plasma membrane. J. Biol. Chem. 268: 3364-3373.
28. Bratton, D. L., E. Dreyer, J. M. Kailey, V. A. Fadok, K. L. Clay, and P. M. Henson. 1992. The mechanism of internalization of PAF in activated human neutrophils: enhanced transbilayer movement across the plasma membrane. J. Immunol. 148: 514-523.
29. Scott, G. A., S. E. Jacobs, and A. P. Pentland. 2006. sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism. J. Invest. Dermatol. 126: 855-861.
30. Qiao, J., F. Huang, R. P. Naikawadi, K. S. Kim, T. Said, and H. Lum. 2006. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. Am. J. Physiol. 291: L91-L101.
31. Huang, Y. H., L. Schafer-Elinder, R. Wu, H. E. Claesson, and J. Frostegard. 1999. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin. Exp. Immunol. 116: 326-331.
32. Flamand, N., J. Lefebvre, M. E. Surette, S. Picard, and P. Borgeat. 2006. Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils. J. Biol. Chem. 281: 129-136.
33. Bettache, N., L. Baisamy, S. Baghdiguian, B. Payrastre, P. Mangeat, and A. Bienvenue. 2003. Mechanical constraint imposed on plasma membrane through transverse phospholipid imbalance induces reversible actin polymerization via phosphoinositide 3-kinase activation. J. Cell Sci. 116: 2277-2284.
34. Haque, M. E., and B. R. Lentz. 2004. Roles of curvature and hydrophobic interstice energy in fusion: studies of lipid perturbant effects. Biochemistry 43: 3507-3517.
35. Staneva, G., M. Seigneuret, K. Koumanov, G. Trugnan, and M. I. Angelova. 2005. Detergents induce raft-like domains budding and fission from giant unilamellar heterogeneous vesicles: a direct microscopy observation. Chem. Phys. Lipids 136: 55-66.
36. Williamson, P. K., L. Algarin, J. Bateman, H.-R. Choe, and R. A. Schlegel. 1985. Phospholipid asymmetry in human erythrocyte ghosts. J. Cell. Physiol. 123: 209-214.
37. Frasch, S. C., P. M. Henson, K. Nagaosa, M. B. Fessler, N. Borregaard, and D. L. Bratton. 2004. Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils. J. Biol. Chem. 279: 17625-17633.
38. Kabarowski, J. H., J. D. Feramisco, L. Q. Le, J. L. Gu, S. W. Luoh, M. I. Simon, and O. N. Witte. 2000. Direct genetic demonstration of Gα13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement. Proc. Natl. Acad. Sci. USA 97: 12109-12114.
39. Yang, L. V., C. G. Radu, L. Wang, M. Riedinger, and O. N. Witte. 2005. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105: 1127-1134.
40. Yun, M. R., F. Okajima, and D. S. Im. 2004. The action mode of lysophosphatidylcholine in human monocytes. J. Pharmacol. Sci. 94: 45-50.
41. Lin, P., and R. D. Ye. 2003. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol. Chem. 278: 14379-14386.
42. Park, K. S., H. Y. Lee, M. K. Kim, E. H. Shin, and Y. S. Bae. 2005. Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes. Biochem. Biophys. Res. Commun. 333: 353-358.
43. Park, K. S., H. Y. Lee, M. K. Kim, E. H. Shin, S. H. Jo, S. D. Kim, D. S. Im, and Y. S. Bae. 2006. Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. Mol Pharmacol. 69: 1066-1073.
44. Borregaard, N., and J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
45. Gainetdinov, R. R., R. T. Premont, L. M. Bohn, R. J. Lefkowitz, and M. G. Caron. 2004. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27: 107-144.
46. Jones, B. W., and P. M. Hinkle. 2005. β-Arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor. J. Biol. Chem. 280: 38346-38354.
47. Naik, S., C. K. Billington, R. M. Pascual, D. A. Deshpande, F. P. Stefano, T. A. Kohout, D. M. Eckman, J. L. Benovic, and R. B. Penn. 2005. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J. Biol. Chem. 280: 8722-8732.
48. Xu, Y., X. J. Fang, G. Casey, and G. B. Mills. 1995. Lysophospholipids activate ovarian and breast cancer cells. Biochem J. 309: 933-940.
49. Kawamoto, K., J. Aoki, A. Tanaka, A. Itakura, H. Hosono, H. Arai, Y. Kiso, and H. Matsuda. 2002. Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J. Immunol. 168: 6412-6419.
50. Sugo, T., H. Tachimoto, T. Chikatsu, Y. Murakami, Y. Kikukawa, S. Sato, K. Kikuchi, T. Nagi, M. Harada, K. Ogi, et al. 2006. Identification of a lysophosphatidylserine receptor on mast cells. Biochem. Biophys. Res. Commun. 341: 1078-1087.
51. Stafford, R. E., T. Fanni, and E. A. Dennis. 1989. Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry 28: 5113-5120.
52. Kern, R., D. Joseleau-Petit, M. K. Chattopadhyay, and G. Richarme. 2001. Chaperone-like properties of lysophospholipids. Biochem. Biophys. Res. Commun. 289: 1268-1274.
53. 1. Biochim. Biophys. Acta 1582: 26-32.
54. 2. J. Immunol. 151: 5675-5684.
55. 2. Crit. Rev. Immunol. 17: 225-283.
56. Bulenger, S., S. Marullo, and M. Bouvier. 2005. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26: 131-137.
57. Park, P. S., S. Filipek, J. W. Wells, and K. Palczewski. 2004. Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43: 15643-15656.
58. Zhang, X. M., Y. Kimura, and M. Inui. 2005. Effects of phospholipids on the oligomeric state of phospholamban of the cardiac sarcoplasmic reticulum. Circ. J. 69: 1116-1123.
59. Morris, D. A., R. McNeil, F. J. Castellino, and J. K. Thomas. 1980. Interaction of lysophosphatidylcholine with phosphatidylcholine bilayers: a photo-physical and NMR study. Biochim. Biophys. Acta 599: 380-390.
60. Harrison, C., and P. H. van der Graaf. 2006. Current methods used to investigate G protein coupled receptor oligomerization. J. Pharmacol. Toxicol. Methods 54: 26-35.
61. Vauquelin, G., and I. Van Liefde. 2005. G protein-coupled receptors: a count of 1001 conformations. Fundam. Clin. Pharmacol. 19: 45-56.
62. 2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J. Biol. Chem. 280: 28044-28052.
63. Kitagawa, T., K. Inoue, and S. Nojima. 1976. Effect of albumin and methylated albumin on the glucose permeability of lipid membranes. J. Biochem. 79: 1135-1145.
64. 2 in arachidonic acid release from human neutrophils. J. Immunol. 164: 2084-2091.
65. Perrin-Cocon, L., S. Agaugue, F. Coutant, P. Saint-Mezard, A. Guironnet-Paquet, J. F. Nicolas, P. Andre, and V. Lotteau. 2006. Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine 24: 1254-1263.
66. Aprahamian, T., I. Rifkin, R. Bonegio, B. Hugel, J. M. Freyssinet, K. Sato, J. J. Castellot, Jr., and K. Walsh. 2004. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199: 1121-1131.
67. Bruni, A., and G. Toffano. 1982. Lysophosphatidylserine, a short-lived intermediate with plasma membrane regulatory properties. Pharmacol. Res. Commun. 14: 469-484.
68. Le, L. Q., J. H. Kabarowski, Z. Weng, A. B. Satterthwaite, E. T. Harvill, E. R. Jensen, J. F. Miller, and O. N. Witte. 2001. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14: 561-571.